Skip to main content

Table 4 Overview of the comparative framework of influenza surveillance systems

From: National influenza surveillance systems in five European countries: a qualitative comparative framework based on WHO guidance

  

France

Germany

Italy

Spain

United Kingdom (England & Wales)

Surveillance sub-system

Outcome

Santé publique France

RKI Arbeitsgemeinschaft für Influenza

Istituto Superiore di Sanita

Instituto de Salud Carlos III

Public Health England

Public Health Wales

1. Non-medically attended community surveillance

1.1. ARI/ILI cases and/or incidence rates

Web-survey (Grippe.net) & Phone advice line (SOS Médecins)

Web-survey (GrippeWeb)

Web-survey (InfluWeb)

Web-survey (GripeNet)

Web-survey (Flusurvey.net), web queries (Fludetector) & Phone advice line (NHS 111 Calls)

Web-survey (Flusurvey.net), Phone advice line (NHS Direct Wales)

1.2. Proportion of ARI/ILI cases attending a physician

2. Virological surveillance

2.1. ARI / ILI specimens for virus typing & subtyping

1 WHO NIC with 3 labs (including 1 WHO H5 and isolates from Réseau Sentinelles & RENAL)

1 WHO NIC (NRZ) (including isolates from regional labs)

1 WHO NIC & InfluNet-Vir (20 labs)

3 WHO NIC & sentinel labs (ReLEG)

1 WHO CC, 1 WHO ERL, NIC & Sentinel labs (Respiratory Datamart)

Public Health Wales Microbiology services

2.2. ARI / ILI specimens for virus genome sequencing

1 WHO NIC

3 WHO NIC

1 WHO CC, 1 WHO ERL & 1 NIC

2.3. ARI / ILI specimens for antiviral drug resistance

3. Community surveillance

3.1.. Notified biologically/laboratory-confirmed cases

Sentinel labs (RENAL)

Mandatory notification (IfSG)

None or unpublished

Sentinel Labs (ReLEG)

Sentinel labs (Respiratory Datamart)

4. Outbreak surveillance

4.1. ARI/ILI outbreaks in closed settings

Care homes (Ehpad)

None

Unpublished

Schools, care homes, medical settings

Schools (MOSA) & care homes (PHE surveillance scheme)

PH Wales Health Protection team

4.2. Biologically/laboratory-confirmed outbreaks in closed settings

Mandatory notification (IfSG)

Unpublished

5. Primary care surveillance

5.1. ARI/ILI GP visits and/or incidence rates

1450 ARI & ILI Sentinel GPs (Réseau Sentinelles) & Phone advice line (SOS Médecins)

830 ARI sentinel GPs (AGI-Sentinel)

1000 ILI sentinel GPs (Influnet-Epi & Vir)

770 Sentinel GPs & mandatory notification (EDOs)

200–500 ILI sentinel GPs (RCGP RSC)

GP Sentinel Surveillance of Infections Scheme

5.2. Biologically/laboratory-confirmed GP visits and/or incidence rates

300 ARI & ILI Sentinel GPs

770 Sentinel GPs (SVGE)

5.3. Influenza-associated excess GP visits

None

Statistical modelling (RKI model)

None

None

None

None

5.4. Influenza-associated excess work loss cases

None

None

None

None

None

6. Hospital surveillance

6.1. ILI or biologically/laboratory-confirmed emergency department visits

~ 700 ARI sentinel hospitals (OSCOUR)

None

Unpublished

None

25 ARI sentinel hospitals (EDSSS)

ARI Sentinel hospitals

6.2. SARI/ILI hospital admissions

~ 73 SARI sentinel hospitals (ICOSARI)

Unpublished

ARI (Chosp) & 100 SARI (CGHCG) sentinel hospitals

44 ARI sentinel hospitals (USISS)

6.3. Biologically/laboratory-confirmed hospital admissions

Mandatory notification (IfSG)

Unpublished

6.4. Influenza-associated excess hospital admissions

None

Statistical modelling (RKI model)

None

None

None

None

6.5 Biologically/laboratory-confirmed ICU admissions

~ 192 SARI Sentinel hospitals (SpF)

None

SARI sentinel hospitals

ARI (Chosp) & 100 SARI (CGHCG) sentinel hospitals

All ICUs (USISS mandatory)

PH Wales Health Protection team

7. Mortality surveillance

7.1 Diagnosed or biologically/laboratory-confirmed influenza deaths

~ 192 SARI Sentinel hospitals (SpF) & death registries (SurSaUD & CépiDc)

Mandatory notification (IfSG)

SARI sentinel hospitals

ARI (Chosp) & 100 SARI (CGHCG) sentinel hospitals

All ICUs (USISS mandatory)

PH Wales Health Protection team

7.2. Influenza-associated excess deaths

Statistical modelling (SurSaUD, CépiDc, SpF algorithm & FluMOMO)

Statistical modelling (RKI algorithm + FluMOMO in Berlin & Hesse)

Statistical modelling (Sismg EuroMOMO)

Statistical modelling (EuroMOMO)

Statistical modelling (FluMOMO)

Statistical modelling (EuroMOMO)

  1. None = there are no surveillance tools covering this outcome; unpublished = these outcomes are covered by surveillance tools but the data are not published in the weekly or annual reports.
  2. AGI Arbeitsgemeinschaft Influenza (influenza working group), CépiDC Centre d’épidémiologie sur les causes médicales de décès (epidemiological center on medical causes of deaths), CGHCG Casos graves hospitalizados confirmados de gripe (severe hospitalised influenza cases), EDO Enfermedades de Declaración Obligatoria (disease under mandatory notification), EDSSS Emergency Department Syndromic Surveillance System, Ehpad Etablissement d’Hébergement pour Personnes Âgées Dépendantes (nursing home), GP general practitioner, ICOSARI Hospital surveillance system for severe acute respiratory infections, IfSG Infektionsschutzgesetz (law on protection against infectious diseases), MOMO Mortality Monitoring, MOSA Medical Officers of Schools Association, NHS National Health System, NIC National Influenza Center, NRZ Nationales Referenzzentrum für Influenzaviren, OSCOUR Organisation de la Surveillance COordonnée des Urgences (organisation for coordinated emergency department surveillance), PH public health, PHE Public Health England, RCGP RSC Royal College of General Practitioners Research and Surveillance Centre, ReLEG Red de Laboratorios de Gripe en España (Spanish network of laboratories for influenza), RENAL Réseau national des laboratoires hospitaliers (network of hospital laboratories), RKI Robert Koch Institute, (S) ARI (severe) acute respiratory illness, Sismg Sistema di Sorveglianza della Mortalità Giornaliera (daily mortality surveillance system); Santé publique France, SurSaUD Surveillance Sanitaire des Urgences et des Décès (public health surveillance of emergencies and deaths), SVGE Sistema Centinela de Vigilancia de Gripe en España (Spanish influenza surveillance sentinel system), USISS UK Severe Influenza Surveillance System, WHO CC World Health Organization Collaborating Centre, WHO ERL WHO Essential Regulatory Laboratory.